Your session is about to expire
← Back to Search
SUPPORT online platform for people with type 1 diabetes for Diabetic Hypoglycemia (SUPPORT Trial)
N/A
Waitlist Available
Led By Anne-Sophie Brazeau, PhD
Research Sponsored by McGill University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-month, and 12-month
Awards & highlights
No Placebo-Only Group
Summary
This trial will test a web-based training platform to see if it is more effective than the current system in teaching people with type 1 diabetes how to use new therapies and technologies to reduce the fear and frequency of hypoglycemia.
Eligible Conditions
- Diabetic Hypoglycemia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6-month, and 12-month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-month, and 12-month
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Users' satisfaction of the SUPPORT platform
Secondary study objectives
Change in the frequency and the fear of hypoglycemia
Change in the glycated hemoglobin
Knowledge about diabetes self-management
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
The intervention group will have immediate access to the SUPPORT platform.
Find a Location
Who is running the clinical trial?
McGill UniversityLead Sponsor
408 Previous Clinical Trials
1,018,133 Total Patients Enrolled
Institut de Recherches Cliniques de MontrealOTHER
70 Previous Clinical Trials
10,093 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,386 Previous Clinical Trials
26,515,700 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have other health conditions that make it difficult for you to manage your diabetes or use the platform, such as dementia or blindness.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger